Skip to content
24/7NewsPaper
Back to feed
Bloombergbloomberg.com

AbbVie to Buy Apogee Therapeutics for $10.9 Billion (opens original article in a new tab)

TL;DR

AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion to strengthen its position in dermatology.

  • AbbVie acquires Apogee Therapeutics for $10.9 billion
  • Deal expands AbbVie's dermatology portfolio with eczema treatments
Back to feedRead original

Conversation

No comments yet

Threaded discussion is coming next — this is where the community conversation about this story will live.